This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Injury of nerves at ankle and foot level
ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
261 |
4. Check minimum number of eventsNone |
261 |
5. Include endpointsNone |
261 |
6. Filter based on genotype QC (FinnGen only) |
261 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesio nervorum regionis tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Injury of nerves at ankle and foot level
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 261 | 146 | 115 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 45.55 | 42.28 | 49.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 229
- Matched controls
- 2289
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S94.3
ICD-10 Finland
Injury of cutaneous sensory nerve at ankle and foot level
+∞
96.9
86
*
S94.2
ICD-10 Finland
Injury of deep peroneal nerve at ankle and foot level
+∞
42.0
39
*
S94.8
ICD-10 Finland
Injury of other nerves at ankle and foot level
+∞
40.9
38
*
S94.9
ICD-10 Finland
Injury of unspecified nerve at ankle and foot level
+∞
32.0
30
*
S93.4
ICD-10 Finland
Sprain and strain of ankle
9.8
25.1
53
68
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.5
22.6
102
346
X58
ICD-10 Finland
Exposure to other specified factors
5.8
21.8
69
158
X59
ICD-10 Finland
Exposure to unspecified factor
4.9
21.2
81
229
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
206.1
18.8
19
*
S94.0
ICD-10 Finland
Injury of lateral plantar nerve
+∞
17.9
17
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
8.6
17.6
39
53
S94.7
ICD-10 Finland
Injury of multiple nerves at ankle and foot level
+∞
15.8
15
*
N03AX16
ATC
pregabalin; oral
3.6
15.7
86
325
N03AX12
ATC
gabapentin; oral
4.4
15.1
60
170
M79.6
ICD-10 Finland
Pain in limb
3.2
14.4
104
476
W19
ICD-10 Finland
Unspecified fall
5.6
14.3
43
90
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.6
11.9
35
71
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
7.7
11.7
27
39
M25.5
ICD-10 Finland
Pain in joint
2.9
11.6
88
401
S94.1
ICD-10 Finland
Injury of medial plantar nerve
+∞
11.5
11
*
N06AX21
ATC
duloxetine; oral
4.4
11.5
43
113
N02BE01
ATC
paracetamol; systemic, rectal
3.9
11.2
207
1621
S91.3
ICD-10 Finland
Open wound of other parts of foot
19.0
10.9
16
9
M19.0
ICD-10 Finland
Primary arthrosis of other joints
5.0
10.3
33
74
WX320
NOMESCO Finland
Spinalanesthesy
3.1
10.2
66
268
S18
ICPC
Laceration/cut
2.5
10.0
107
587
L16
ICPC
Ankle symptom/complaint
4.4
9.6
35
90
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
18.5
9.5
14
8
S93.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of foot
104.1
9.5
10
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
9.4
121
724
R4110
NOMESCO Finland
Physiotherapy
2.7
9.3
74
340
TQW40
NOMESCO Finland
Remowal of suture of skin
5.5
9.3
27
54
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
19.6
9.0
13
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.9
9.0
38
112
N02AX02
ATC
tramadol; systemic, rectal
2.4
8.9
106
606
NH1AD
NOMESCO Finland
Ankle and foot CT
14.8
8.8
14
10
W22
ICD-10 Finland
Striking against or struck by other object(s)
5.1
8.8
27
58
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.4
8.8
20
29
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
8.4
32
86
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
8.4
101
575
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
15.2
8.3
13
9
S06.0
ICD-10 Finland
Concussion
3.9
8.2
34
99
ZXA00
NOMESCO Finland
Right side
2.6
7.8
66
311
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
15.7
7.8
12
8
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
46.6
7.8
9
*
ACC29
NOMESCO Finland
Reconstruction of peripheral nerve: other or unspecified
46.6
7.8
9
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
10.6
7.6
14
14
S92.3
ICD-10 Finland
Fracture of metatarsal bone
26.0
7.6
10
*
A02BC02
ATC
pantoprazole; systemic
2.2
7.5
149
1049
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.2
7.5
28
74
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
7.4
35
114
N06AA09
ATC
amitriptyline; systemic
3.9
7.3
30
86
N03AX09
ATC
lamotrigine; oral
5.1
7.2
22
47
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
31.1
7.2
9
*
M89.0
ICD-10 Finland
Algoneurodystrophy
14.4
7.0
11
8
XA402
NOMESCO Finland
ENMG
7.1
6.9
16
24
S82.6
ICD-10 Finland
Fracture of lateral malleolus
4.4
6.9
24
59
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
9.8
6.9
13
14
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
11.4
6.9
12
11
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.2
6.9
20
41
T93.2
ICD-10 Finland
Sequelae of other fractures of lower limb
17.3
6.8
10
6
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
10.5
6.6
12
12
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
6.6
69
360
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
71.7
6.5
7
*
B01AB05
ATC
enoxaparin; parenteral
2.2
6.4
72
388
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
6.4
56
266
M54.5
ICD-10 Finland
Low back pain
2.2
6.4
83
475
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
6.3
71
379
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
18.6
6.3
9
5
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.8
6.1
16
29
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
6.1
32
113
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.0
6.1
18
38
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
6.0
171
1335
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
160
1201
1.86
5.48
9.3
9.2
4.3
4.1
e9/l
0.48
138
1044
142
1037
1.81
5.23
6.8
6.2
11.2
10.9
umol/l
0.18
135
978
25
95
2.80
4.98
1.8
1.6
—
—
—
0
0
52
278
2.09
4.92
2.2
1.8
—
—
—
0
0
73
453
1.85
4.46
2.1
1.7
0.9
1.1
mg/l
0.58
52
346
110
772
1.73
4.43
4.6
4.6
35.0
36.6
g/l
1.90
102
727
187
1524
1.80
4.37
4.9
3.6
10.2
9.6
mm/h
0.33
173
1415
101
711
1.69
3.92
2.2
1.8
100.4
96.4
pmol/l
0.37
59
367
55
325
1.88
3.88
3.2
3.4
1020.8
146.3
ng/l
0.59
35
225
73
476
1.74
3.72
3.2
2.1
—
—
—
0
0
40
215
2.02
3.71
12.3
17.2
1.0
1.3
inr
—
8
31
128
973
1.62
3.60
4.3
3.9
—
—
—
0
0
19
75
2.65
3.55
2.9
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
36
3.45
3.52
2.6
2.1
0.3
0.3
u/ml
—
7
21
11
32
3.54
3.37
1.7
1.2
—
—
—
0
0
20
85
2.47
3.24
2.0
1.8
—
—
—
0
0
68
454
1.67
3.13
2.4
2.0
3.2
3.0
mg/l
0.27
55
388
185
1568
1.62
3.09
9.0
7.1
76.2
74.6
u/l
0.24
174
1472
114
870
1.55
3.00
6.6
6.3
1.2
1.2
mmol/l
0.10
103
737
107
810
1.54
2.89
6.9
5.4
1.2
1.2
mmol/l
0.20
100
733
6
9
6.79
2.88
4.3
1.6
—
—
—
0
0
76
533
1.60
2.86
3.5
2.7
0.2
0.3
e6/l
0.26
60
400
144
1168
1.52
2.80
5.8
4.3
6.4
6.6
mmol/l
0.38
137
1069
17
73
2.42
2.71
2.9
1.9
—
—
—
0
0
105
808
1.50
2.56
2.4
2.2
72.8
75.5
nmol/l
0.54
93
726
233
2131
1.87
2.56
18.0
12.8
139.5
139.7
mmol/l
0.53
228
2072
234
2143
1.89
2.56
17.6
12.9
4.0
4.0
mmol/l
0.20
229
2080
223
2016
1.73
2.53
14.8
10.8
87.8
87.3
ml/min/173m2
0.12
191
1630
95
719
1.51
2.50
3.1
3.0
33.7
30.6
u/l
0.35
90
683
77
557
1.54
2.50
2.4
2.1
1038.7
375.7
u/l
0.43
72
527
27
146
1.95
2.48
2.7
3.5
3.4
2.1
mmol/l
0.68
18
108
32
187
1.81
2.34
1.9
1.6
—
—
—
0
0
45
293
1.65
2.26
2.7
2.5
2.1
2.8
e6/l
0.21
22
154
94
723
1.47
2.25
3.5
3.2
16.7
34.7
ng/l
2.07
56
447
59
413
1.55
2.20
1.6
1.4
18.3
20.6
nmol/l
0.68
48
351
233
2151
1.78
2.20
18.3
11.8
19.7
21.7
mg/l
0.48
197
1655
31
186
1.76
2.09
2.0
1.7
—
—
—
0
0
46
308
1.60
2.07
2.8
2.4
1.2
0.7
e6/l
0.24
23
169
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
7
20
3.57
2.07
1.4
2.0
—
—
—
0
0
5
12
4.23
1.83
1.0
1.3
—
—
—
0
0
21
118
1.85
1.76
2.3
1.6
—
—
—
0
0
87
686
1.40
1.76
3.7
2.9
—
—
—
0
0
179
1589
1.40
1.75
3.8
3.9
14.6
14.7
pmol/l
0.14
165
1453
50
356
1.50
1.72
1.3
1.3
11.7
25.0
iu/ml
1.79
16
120
5
13
3.90
1.72
1.0
1.1
186.8
128.5
iu/ml
—
5
13
7
25
2.85
1.66
1.0
1.2
—
—
—
0
0
7
25
2.85
1.66
1.0
1.2
—
—
—
0
0
11
49
2.30
1.66
1.0
1.8
—
—
—
0
0
180
1608
1.38
1.64
3.4
3.5
—
—
—
0
0
43
300
1.52
1.63
2.0
1.6
995.4
1198.0
nmol/l
0.84
30
236
242
2295
1.75
1.56
12.1
9.2
28.7
26.8
u/l
0.92
236
2230
23
139
1.72
1.54
2.3
2.1
15.2
8.2
ug/l
0.35
15
125
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.38
1.53
1.0
1.3
—
—
—
0
0
11
51
2.21
1.53
3.3
2.3
—
—
—
0
0
6
23
2.65
1.37
1.3
2.0
—
—
—
0
0
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
62
485
1.37
1.29
1.8
1.5
—
—
—
0
0
6
26
2.34
1.19
1.2
1.3
—
—
—
0
0
6
26
2.34
1.19
1.3
2.0
—
—
—
0
0
46
347
1.40
1.19
1.3
1.3
1.1
8.3
u/ml
2.65
15
144
45
339
1.40
1.17
2.2
1.7
1.6
1.4
%
0.97
40
303
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
7
32
2.22
1.09
1.9
1.3
—
—
—
0
0
77
638
1.29
1.07
3.5
2.5
72.3
54.5
u/l
0.53
72
597
74
611
1.29
1.06
2.5
3.4
2.3
2.3
mmol/l
0.01
63
546
206
1932
1.31
1.01
5.0
4.5
1.7
2.4
mu/l
0.63
193
1784
5
23
2.20
0.98
1.4
2.1
6.5
7.2
mmol/l
—
5
16
30
218
1.42
0.97
8.6
6.8
105.3
104.1
mmol/l
0.79
30
213
9
51
1.79
0.95
1.8
1.6
—
—
—
0
0
217
2055
1.33
0.95
17.0
12.0
40.6
40.7
%
0.05
179
1631
41
316
1.35
0.95
2.1
2.8
2.5
2.4
mmol/l
0.71
36
280
6
28
2.17
0.92
1.3
1.4
—
—
—
0
0
57
464
1.29
0.91
3.1
2.9
969.4
1154.2
ng/l
0.26
47
385
116
1027
1.23
0.91
3.6
3.3
0.0
0.0
estimate
0.00
23
207
26
187
1.43
0.89
3.0
3.2
—
—
—
0
0
32
241
1.37
0.86
5.3
3.9
29.9
31.8
%
0.41
20
163
12
73
1.67
0.83
1.6
1.1
—
—
—
0
0
14
90
1.59
0.80
3.4
9.2
24.5
24.2
mmol/l
0.14
14
83
12
74
1.65
0.79
1.6
1.1
—
—
—
0
0
9
54
1.69
0.75
1.9
1.1
—
—
—
0
0
219
2099
1.27
0.70
4.1
4.0
4.8
4.7
mmol/l
0.66
203
1979
198
1881
1.22
0.66
5.9
4.9
38.6
39.1
mmol/mol
0.32
186
1776
113
1023
1.18
0.66
5.1
4.5
0.0
0.0
estimate
0.00
25
210
25
190
1.35
0.65
9.2
7.6
2.8
1.0
mmol/l
0.90
19
147
59
504
1.22
0.64
1.4
1.3
0.8
1.2
u/ml
0.58
19
151
11
71
1.57
0.63
1.3
1.2
—
—
—
0
0
114
1036
1.18
0.63
3.6
3.3
0.0
0.0
estimate
0.00
23
198
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
5
30
1.68
0.61
1.6
1.6
—
—
—
0
0
167
1569
1.18
0.60
3.8
2.9
58.4
43.7
u/l
0.91
160
1488
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
3.5
—
86.2
—
0
23
58
500
1.21
0.57
2.8
2.6
13180.6
7212.3
umol/l
0.19
47
437
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
10
65
1.56
0.56
1.2
1.3
—
8.6
—
0
12
6
39
1.55
0.53
1.2
1.2
—
—
—
0
0
104
949
1.16
0.53
3.2
2.7
97.3
100.9
ug/l
0.11
98
885
9
134
0.66
0.53
7.7
3.7
1.2
1.2
mmol/l
—
9
116
48
557
0.83
0.52
4.2
3.5
0.0
0.0
estimate
0.00
25
206
6
40
1.51
0.52
1.8
1.6
—
—
—
0
0
14
101
1.41
0.50
1.3
1.4
249.0
316.4
miu/ml
—
8
48
7
46
1.54
0.48
2.1
1.5
—
—
—
0
0
15
111
1.37
0.48
1.3
1.3
—
—
—
0
0
216
2090
1.19
0.47
4.2
3.9
1.4
1.4
mmol/l
1.94
200
1959
7
49
1.44
0.46
2.0
1.6
—
—
—
0
0
7
49
1.44
0.46
1.4
1.3
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
31
1.62
0.43
1.6
1.6
—
—
—
0
0
5
32
1.57
0.42
1.6
1.6
—
—
—
0
0
8
58
1.39
0.42
1.3
1.3
—
46.6
—
0
6
5
33
1.52
0.41
2.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
1.1
—
0
5
8
59
1.37
0.41
1.5
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
30
355
0.82
0.41
1.3
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
62
556
1.15
0.40
1.6
1.6
1.6
1.4
mmol/l
0.65
56
477
0
19
0.00
0.39
0.0
1.0
—
56.1
—
0
9
18
143
1.28
0.38
1.9
1.3
—
—
—
0
0
19
153
1.26
0.36
2.6
2.8
79.2
70.2
ml/min/173m2
—
10
67
21
253
0.82
0.35
1.7
1.7
—
—
—
0
0
15
188
0.79
0.34
1.4
1.6
—
—
—
0
0
10
74
1.37
0.33
1.5
1.5
—
—
—
0
0
32
365
0.86
0.30
3.2
2.6
0.7
0.7
ug/l
0.02
19
222
207
2021
1.12
0.27
3.8
3.5
1.4
1.3
mmol/l
1.52
192
1881
8
66
1.22
0.27
2.9
1.9
160.6
226.9
pmol/l
—
8
61
8
67
1.20
0.26
1.0
1.8
—
—
—
0
0
5
38
1.32
0.23
2.2
1.6
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
45
490
0.90
0.22
3.8
4.0
19.8
20.7
%
0.11
17
219
217
2131
1.11
0.22
4.5
4.3
2.8
2.8
mmol/l
0.09
201
1995
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
8
103
0.77
0.21
1.8
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.17
0.21
6.2
2.5
254.0
75.8
ug/min
—
5
29
0
13
0.00
0.21
0.0
1.6
—
1.5
—
0
8
6
48
1.26
0.20
1.3
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
25
222
1.14
0.20
2.2
1.9
—
—
—
0
0
7
58
1.21
0.18
1.6
1.1
—
—
—
0
0
205
2014
1.08
0.18
4.7
4.0
5.8
5.8
mmol/l
0.00
190
1865
66
625
1.07
0.17
4.9
4.4
6.2
2.0
ug/l
0.52
60
561
16
183
0.87
0.16
3.0
2.3
14.7
14.5
nmol/l
0.03
11
173
18
159
1.14
0.15
12.1
8.4
126.7
122.7
g/l
0.28
18
151
45
421
1.08
0.15
2.0
2.2
—
—
—
0
0
5
45
1.11
0.10
1.6
1.3
194.3
232.6
u/ml
—
5
29
12
134
0.89
0.09
1.1
1.0
—
—
—
0
0
5
64
0.78
0.08
1.6
1.5
—
—
—
0
0
8
92
0.87
0.07
1.5
1.4
—
—
—
0
0
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
9
102
0.88
0.06
1.2
1.5
—
—
—
0
0
83
813
1.03
0.05
3.7
3.4
—
—
—
0
0
11
102
1.08
0.03
28.4
8.0
27.5
24.4
mmol/l
0.93
11
93
11
117
0.94
0.02
1.4
1.6
—
—
—
0
0
19
183
1.04
0.01
1.8
1.7
—
—
—
0
0
22
227
0.97
0.01
10.2
6.3
—
—
—
0
0
39
383
1.02
0.01
1.8
2.0
—
—
—
0
0
11
104
1.06
0.01
4.6
5.2
24.1
24.6
mmol/l
0.15
11
104
12
123
0.97
0.00
1.4
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
8
83
0.96
0.00
1.7
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
29.2
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
0.00
1.2
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
6.5
—
0
9
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_NERVES_ANKLE_FOOT_LEVEL – Injury of nerves at ankle and foot level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).